🎄✨ Thank You from Pharmidex! ✨🎄
December 19, 2024
As the year comes to a close, everyone at
Pharmidex would like to take this opportunity to express our heartfelt gratitude for your trust, support, and partnership.
We wish you a healthy, happy, and prosperous new year ahead! 🌟
In keeping with our tradition, we are proud to support charities that make a meaningful difference in people's lives. Here's to another year of collaboration and innovation together!
The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
